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Abstract
Depression has been linked to poor health outcome in a number
of studies; however, the mechanism underlying this relationship
has received little attention. This paper explores the possibility that
adherence mediates the relationship between depression and
outcome. Principal findings regarding the relationship between
depression, adherence, and outcome are reviewed. The data
suggest that depression is related, at least moderately, to poorer
adherence to a variety of treatment components. The relationship
between adherence and outcome is more difficult to establish. In
addition, current data, albeit limited, do not support the hypothesis
that adherence mediates the relationship between depression and
outcome. An alternative model in which adherence precedes and
influences both mood state and health outcome is discussed.
Finally, possible explanations for these relationships are explored
and suggestions for future research provided.
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Introduction

Depression has been associated with poor health out
comes in a variety of medical conditions. For example,
depression has been linked to higher glycosylated hemo
globin in both type 1 and type 2 diabetes mellitus [1]. An
important issue is to determine the mechanism underlying
this relationship. One possibility, considered here, is that
depressed patients are less adherent to their treatment
regimens, and this lack of adherence produces poorer health
outcomes (Fig. 1).

Studies of the relationship between depression and
adherence have used a variety of approaches to assess
depression or depressive symptomatology (ranging from
questionnaires, such as the Center for Epidemiologic
Studies-Depression questionnaire or the Beck Depression
Inventory, to clinical interviews). Likewise, different
aspects of adherence (adherence to diet, exercise, glucose
monitoring, medication adherence, attendance at treatment
sessions), different criteria for defining adherence, and
different approaches to measuring adherence have been
used. While acknowledging that these methodological
differences may affect results, and recognizing that adherence
to one aspect of the regimen may be unrelated to adherence to
other aspects [2], we have focussed this paper on some of the
general and consistent findings regarding the relationship
between depression, adherence, and outcome. We have also
considered other possible interrelationships among these
variables, using exercise and obesity as examples.
The term ‘‘adherence’’ is used in preference to the term
‘‘compliance’’ throughout the paper to recognize the import
ance of the partnership between patient and provider in all
aspects of medical care.

Does depression affect adherence?
Many studies have examined the association between
depression and treatment adherence. It is well recognized
that adherence to pharmacologic regimens for depression is
very poor, with only 40% of those receiving an antidepres
sant prescription completing the 9-month recommended
treatment [3]. Adherence to medical regimens is also poor
in depressed patients. A meta-analysis of this literature
included 12 studies published from 1968 to 1998 that
measured depression and adherence to a medical regimen
recommended by a nonpsychiatrist physician [4]. Six of
these studies involved patients with end-stage renal disease

Fig. 1. Model showing adherence as the mediator of the relationship
between depression and health outcome.

or renal transplants and six involved other medical diseases
(angina, cancer, arthritis). The relationship between depres
sion and nonadherence was found to be consistent across
studies and of moderate size (Table 1). The odds that an
individual would be nonadherent were three times greater
for depressed patients than for nondepressed patients. In
contrast, this meta-analysis found no consistent relationship
between anxiety and treatment adherence.
Two recent studies reinforce this finding. In one study
[5], 204 patients were interviewed for depression 3 – 5 days
after a myocardial infarction and then re-contacted 4 months
later to assess adherence to cardiac risk reduction recom
mendations. Patients who reported no current mood disorder
were compared to those with major depression/dysthymia
(based on the Structured Clinical Interview for Axis I
Disorders). The depressed patients reported lower adherence
to several aspects of the regimen, including exercise, low-fat
diet, stress reduction, and prescription medication. No
differences were observed for other aspects of the regimen
such as stopping smoking, following a low sodium diet, or
carrying medical supplies.
Another study [6] included 367 patients with diabetes
who were seen in primary care clinics of a large health
maintenance organization. Depressive symptoms were
assessed with the Hopkins Symptom Checklist—90 Re
vised; adherence was assessed by self-report and by using
an automated data collection system for refills of hypogly
cemic medication. Higher levels of depressive symptoms
were associated with poorer adherence to the diet (amount
and type of food) and with more days of interruption of
hypoglycemic medication therapy. There was no association
between depressive symptom severity and self-reported
adherence to exercise or glucose monitoring.
Thus, depression appears to be related, at least moder
ately, to poorer adherence to a variety of treatment compo
nents. It is now important to better understand why
depressed patients are less adherent. There are a variety of
possible explanations. Depressed patients report greater
feelings of hopelessness (and thus may not expect treatment
to be effective). They are often more socially isolated and
social support has been related to adherence. Cognitive
impairment in depressed patients may affect their memory
of the health care prescriptions and recommendations given
by the physician. Finally, depressed patients may not have
the energy to carry out treatment recommendations.
It is also important to consider whether the strength of the
association between depression and adherence is due, in
part, to a methodological artifact. When asked to self-report
their level of adherence, depressed patients may have poor

self-perceptions and underestimate their actual level of
adherence. Thus, it is particularly important to use objective
measures of adherence (such as pill counts or pharmacy
records as used in the Ciechanowski study [6]) in assessing
the relationship between depression and adherence. Further
research is needed to better understand why depressed
patients are less adherent in order to develop effective
approaches to enhance adherence.

Does adherence affect outcome?
The model described in Fig. 1 assumes that depression
affects adherence and that adherence affects outcome. There
is a large literature studying the effect of adherence on
outcome, which will not be reviewed in detail here. In
general, however, it appears that adherence to medication is
related to outcome. A recent review [7] assessed the rela
tionship between medication adherence and morbidity and
mortality in patients who were at risk for coronary artery
disease and congestive heart failure. Seven of 12 studies that
compared hospitalization rates and mortality in adherent and
nonadherent patients showed significant differences. Of
particular note is the fact that adherence to placebo is also
related to outcome.
It is more difficult to establish the relationship between
adherence to behavioral recommendations and outcome. For
example, in some weight loss studies, there are significant
differences in weight loss between groups but no differences
in dietary intake or exercise. This most likely reflects the
difficulty in accurately measuring dietary intake and phys
ical activity. Alternatively, the behaviors being studied may
not be the behaviors that relate directly to outcome. For
example, there may be little or no relationship between
frequency of self-monitoring of blood glucose (SMBG) and
glycosylated hemoglobin because the important behavior is
not merely monitoring glucose levels but rather using the
SMBG information to make adjustments in other aspects of
the regimen.

Does poor adherence mediate the relationship between
depression and outcome?
The question of whether adherence mediates the rela
tionship between depression and outcome of diabetes,

Table 1
Meta-analysis of the relationship between depression and adherence
Psychological variable

Number of studies

Unweighted

Effect size

Depression (Total)
ESRD
Non-ESRD
Anxiety (Total)

12
6
6
13

� 0.27
� 0.30
� 0.25
� 0.04

P < .001
P =.008
P =.005
P =.59

Ref. [4].

obesity, or renal disease has received little empirical study.
One approach to this question is to determine whether the
association between depression and outcome is weakened
or becomes nonsignificant after adjusting for level of
adherence. Gary et al. [8] found that depressive symp
tomatology was associated with higher cholesterol, trigly
cerides, and glycosylated hemoglobin levels in Type 2
diabetic patients. Patients were asked to rate their adher
ence to various aspects of the diabetes regimen on fourpoint scales. Adjusting for level of adherence to diet,
physical activity, smoking, glucose monitoring, and dia
betes medication adherence did not reduce the effect of
depression on these physiological outcome variables. Thus,
this study provided no evidence that adherence mediated
the relation between depression and outcome.
Another approach to determining whether adherence
mediates the relationship between depression and outcome
is to examine whether interventions that reduce depression
and produce improvements in health outcome are associ
ated with improvements in adherence. (If so, analyses
adjusting for the improvement in adherence should reduce
the association between changes in depression and changes
in outcome.) Lustman et al. have conducted two interven
tion studies with depressed patients with diabetes; one
study used an antidepressant medication (nortriptyline) to
treat the depression [9] and the other used cognitive
behavior therapy (CBT) [10]. In both studies, the interven
tion reduced depression and improved glucose control
relative to the control condition. However, there was no
evidence that reducing depression led to improved adher
ence, as measured by the use of home blood glucose
monitoring. In fact, patients who participated in CBT
showed worsening in their adherence to glucose monitoring
relative to the control condition.
Thus, based on these few studies, there is no evidence to
support the hypothesis that adherence mediates the relation
ship between depression and outcome. Further study with
objective measures of adherence, clear criteria for defining
adherence, and assessments of adherence to a variety of
different behaviors is needed.

An alternative model
As discussed above, there are many studies showing a
correlation between depressive symptomatology and behav
ior. These results are often interpreted as implying that
depression causes poor adherence. It is important to recog
nize that in some situations, the direction of the relation may
be reversed — the behaviors may precede and influence the
mood state (Fig. 2). Hence by changing the behavior, it may
be possible to change the mood state (rather than vice
versa). Further, changing the behavior may influence the
health outcome. There may also be indirect effects such that
changing the behavior may influence health outcome
through an effect on mood.

Fig. 2. Alternative model of the relationship between behavioral adherence,
depression, and health outcome.

As an example consider exercise. A number of studies
have shown an association between physical activity and
depression [11]. Although depression may lead to more
sedentary behavior, there are also several studies suggest
ing that low physical activity precedes, and is a risk factor
for, subsequent depression. In the Harvard Alumni study,
for example, physical activity level reported in 1962 and
1966 was associated with increased risk of physiciandiagnosed depression 23 –27 years later [12]. Compared
to those men who reported < 1000 kcal/week of physical
activity, those who reported 1000 – 2499 kcal/week had a
17% reduction in risk of clinically recognized depression
and those who were most active ( > 2500 kcal/week) had a
28% reduction in risk.
Moreover, increasing exercise is an effective treatment
for depression. In a recent study [13], 156 adults with major
depressive disorder were randomly assigned to an exercise
condition (three supervised exercise sessions per week for
16 weeks) or to depression medication (Sertraline), or to the
combination of medication plus exercise. Remission rates
after 4 months were comparable in the three conditions
(60.4% of patients in the exercise group; 65.5% in the
medication group; and 68.8% in the combined group had
remission). Recently, 10-month follow-up data were pre
sented for 133 of the original 156 patients [11]. Patients in
the exercise group had significantly lower relapse rates than
subjects in the medication group. In addition, exercising on
one’s own during follow-up was strongly associated (odds
ratio = 0.49, P =.0009) with reduced risk of a diagnosis of
depression at the end of 10 months.
Obesity and weight control is also an interesting
example. Depressive symptomatology, assessed at the start
of a weight loss program, is not strongly or consistently
associated with weight loss outcome, although in some
studies, depression levels at baseline are associated with
early termination of treatment. In contrast, participation in
a behavioral weight loss program appears to produce
marked, long-term improvements in depressive symp
tomatology. Patients report improvements in mood state
within the first few weeks of a weight loss program, with
improvements over the initial 6-month program apparently
related to the magnitude of weight loss. However, interest
ingly, when participants are followed over time, improve
ment in mood persists even if the weight is regained.

Foster et al. [14] studied 48 patients before and after a
6-month behavioral weight loss program and again at a
58-month follow-up. Body weight averaged 105.8, 84.7,
and 109.4 kg at these three time points, respectively. Beck
Depression Inventory scores were 12.7, 6.0, and 9.3 for the
three time points, and the follow-up levels were signific
antly below ( P =.006) baseline. At follow-up, weight loss
was unrelated to changes in mood. These data suggest that
some aspect of the program (possibly the exercise com
ponent, the social support, or the cognitive behavioral
approach), rather than weight loss per se, produced a
positive change in mood state.
Changing physical activity level and/or weight can affect
health outcomes directly and may also affect health out
comes via improvements in depression. There is extensive
literature showing that physical activity level and body
weight are related to risk of developing diabetes and/or
cardiovascular disease and to mortality. Thus, changing
these behaviors may have a far more dramatic effect on
health outcomes than changing mood state.

Conclusion and future research directions
In conclusion, it is clear that there is a correlation
between depressive symptomatology and adherence behav
iors. It is time that the field moves beyond this simple fact
and begins to ask why this correlation occurs and how it
affects health outcomes. Below are some suggestions for
future research.
1. Better methods to assess adherence
One of the major limitations in this field is the
difficulty of setting criteria for defining adherence and
objectively measuring this construct, especially adherence
to complex behaviors such as diet. As noted above, selfreported behavior may be particularly problematic and
potentially biased in depressed patients. Better ways to
objectively assess key behaviors, such as diet and physical
activity, are clearly needed. It is also important to establish
criteria for determining when a patient is adherent, a task
made more difficult by the fact that many behavioral
prescriptions are given in general terms (e.g., ‘‘increase
your physical activity’’). It is also important to carefully
specify the behaviors that we expect might be related to
outcome. For example, rather than simply assessing fre
quency of self-monitoring of glucose, it is important to
assess the use of SMBG information to regulate other
aspects of the regimen.
2. Research on whether adherence mediates the relationship
between depression and outcome
Future research should more specifically address the
question of whether adherence mediates the relationship

between depression and outcomes. Baron and Kenny [15]
have proposed a methodological approach to studying
mediators that would be helpful in this regard. Studies of
the treatment of depression, where treatment improves
health outcomes, should include objective measures of
adherence. A variety of different aspects of adherence
should be assessed (including adherence to both the depres
sion and medical treatment regimens) since adherence to
various components of the regimen are often not related to
each other, and the combination of behaviors may be more
strongly related to outcome than any one behavior [2].
Again, if the relationship between improvements in depres
sion and health outcome is positive, researchers should
determine whether this relationship is partially or fully
explained by adjusting for adherence.
3. Research to improve adherence in depressed patients
Another approach to understanding the role of adher
ence in mediating the relationship between depression and
outcome is to develop strategies to improve adherence to
the medical treatment regimen for depressed patients and
then determine whether the increased adherence improves
health outcome. For example, simplifying the regimen or
providing adherence reminders may be particularly helpful
for patients with depression. Strategies that empower
patients and encourage the development of an alliance
between patients and providers may also improve adher
ence. In addition, examining whether improving adherence
to pharmacologic or psychological treatment for depres
sion has an effect on health outcome is an important area
of inquiry.
4. Comparing interventions that are aimed at reducing
depression with interventions that focus on behaviors such
as exercise and weight control
Ultimately, the most important question is whether
health outcomes are improved more dramatically by
targeting depression or by targeting other behaviors that
appear to be more directly related to the outcome
(Fig. 2). Physical activity and weight loss have been
shown to be related to the risk of developing diabetes
and appear important in its treatment. Future research
should determine whether diabetes health outcomes (e.g.,
glycosylated hemoglobin, lipids, blood pressure) are
better addressed by reducing depression or by focussing
on behaviors directly related to health outcome. Redu
cing depression with techniques such as CBT or med
ication may improve health outcome through several
mechanisms, including, perhaps, increased physical activ
ity and adherence to dietary recommendations. Alterna
tively, it may be more effective to directly focus on
increasing physical activity or promoting weight loss;
these behavior changes may simultaneously affect both
depression and health outcome.

References
[1] Lustman PJ, Anderson RJ, Freedland KE, DeGroot M, Clouse RE.
Depression and poor glycemic control: a meta-analytic review of the
literature. Diabetes Care 2000;23:934 – 41.
[2] Orme CM, Binik YM. Consistency of adherence across regimen de
mands. Health Psychol 1989;8:27 – 43.
[3] Depression Guideline Panel. Depression in primary care: detection
and diagnosis, vol. 1. Rockville (MD): US Department of Health
and Human Services, Public Health Service, Agency for Health Care
Policy and Research, 1993 (AHCPR publication 93-0550).
[4] Dimatteo RM, Lepper HD, Croghan TW. Depression is a risk factor
for noncompliance with medical treatment; meta-analysis of the ef
fects of anxiety and depression on patient adherence. Arch Intern Med
2000;160:2101 – 7.
[5] Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP,
Bush DE. Patients with depression are less likely to follow recom
mendations to reduce cardiac risk during recovery from a myocardial
infarction. Arch Intern Med 2000;160:1818 – 23.
[6] Ciechanowski PS, Katon WJ, Russo JO. Depression and diabetes:
impact of depressive symptoms on adherence, function, and costs.
Arch Intern Med 2000;3278 – 85.
[7] McDermott MM, Schmitt B, Wallner E. Impact of medication non
adherence on coronary heart disease outcomes. Arch Intern Med
1997;1921 – 9.
[8] Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depres

[9]

[10]

[11]

[12]

[13]

[14]

[15]

sive symptoms and metabolic control in African-Americans with type
2 diabetes. Diabetes Care 2000;23:23 – 9.
Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen S, Rubin
EH, Carney RM, McGill JB. Effects of nortriptyline on depression
and glycemic control in diabetes: results of a double-blind, placebocontrolled trial. Psychosom Med 1997;59:241 – 50.
Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cog
nitive behavior therapy for depression in type 2 diabetes mellitus: a
randomized, controlled trial. Ann Intern Med 1998;129:613 – 21.
Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M,
Moore K, Craighead E, Bladewicz T, Krishnan R. Exercise treatment
for major depression: maintenance of therapeutic benefit at 10 months.
Psychosom Med 2000;62:633 – 8.
Paffenbarger R, Leung R. Physical activity and personal character
istics associated with depression and suicide in American college men.
Acta Psychiatr Scand 1994;377:16 – 22.
Blumenthal JAB, Babyak M, Moore K, Craighead WE, Herman S,
Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M,
Doraiswamy PM, Krishnan KR. Effects of exercise training on older
patients with major depression. Arch Intern Med 1999;159:2349 – 56.
Foster GD, Wadden TA, Swain RMS, Stunkard AJ, Vogt RA. The
Eating Inventory in obese women: clinical correlates and relationship
to weight loss. Int J Obes 1998;22:785.
Baron RK, Kenny DA. The moderator – mediator variable distinction
in social psychological research: conceptual, strategic, and statistical
considerations. J Pers Soc Psychol 1986;51:1173 – 82.

